House to vote on bill to legalize marijuana

House to vote on bill to legalize marijuana


Adam Eidinger along with other DC marijuana advocates gathered on the east side of the US Capitol plaza grounds to urge Congressional lawmakers to lower the restrictions on marijuana use in the District of Columbia, and made a further statement by illegally smoking marijuana and consequently being arrested, on Capitol Hill in Washington DC Monday April 24, 2017. 

Melina Mara | The Washington Post | Getty Images

WASHINGTON — The House is expected to vote Friday on legislation that would legalize marijuana nationwide, eliminating criminal penalties for anyone who manufactures, distributes or possesses the substance.

The legislation, dubbed the Marijuana Opportunity Reinvestment and Expungement Act, passed in the House last year, but did not move forward in the Senate. The bill would also establish procedures for expunging previous convictions from people’s records and impose a tax on the sale of cannabis products.

The tax would begin at 5 percent and eventually increase to 8 percent. Funding raised through the tax would go toward a fund to provide job training, mentoring, substance-use treatment, legal aid, re-entry services and youth recreation programs. It would also provide loans to help small businesses in the cannabis industry that are “owned and controlled by socially and economically disadvantaged individuals,” a summary of the bill said.

“This landmark legislation is one of the most important criminal justice reform bills in recent history,” House Speaker Nancy Pelosi, D-Calif., said in remarks on the floor Thursday about the measure.

Pelosi said the legislation would deliver “justice for those harmed by the brutal, unfair consequences of criminalization,” open opportunities for people to participate in the industry and decriminalize pot at the federal level “so we do not repeat the grave mistakes of our past.”

Thirty-seven states and Washington, D.C. have enacted laws legalizing medical marijuana, with 18 states and D.C. legalizing marijuana for recreational purposes, according to the National Conference of State Legislatures. California became the first state to legalize medical marijuana in 1996. Pelosi highlighted the changes made at the state level over the last few decades.

“Now it is time for the federal government to follow suit,” she said.

Meanwhile, Senate Majority Leader Chuck Schumer, D-N.Y., has been working with Sens. Ron Wyden, D-Ore., and Cory Booker, D-N.J., to craft similar legalization legislation in their chamber. Prospects for passing such a bill in the Senate appear to be low because Democrats would need all of their members and 10 Republicans to overcome a 60-vote hurdle needed to advance to a final vote.



Source

Abortion pill makers brace for restrictions a year after Trump’s election
Health

Abortion pill makers brace for restrictions a year after Trump’s election

Mifepristone and Misoprostol pills are pictured Wednesday, Oct. 3, 2018, in Skokie, Illinois. Erin Hooley | Chicago Tribune | Tribune News Service | Getty Images Just over a year since Donald Trump was elected president again, the $6.9 billion abortion pill industry is operating under the same federal rules he inherited from former President Joe […]

Read More
Republicans push Obamacare tax credit alternatives as enrollment deadline looms
Health

Republicans push Obamacare tax credit alternatives as enrollment deadline looms

An Obamacare sign is displayed outside an insurance agency on Nov. 12, 2025 in Miami, Florida. Joe Raedle | Getty Images With enhanced Obamacare tax credits set to expire at the end of the year, Republicans are proposing new alternatives aimed at lowering the cost of health care. Their window for doing so is rapidly […]

Read More
Novo Nordisk shares plunge 10% after Alzheimer’s drug trial fails to hit key target
Health

Novo Nordisk shares plunge 10% after Alzheimer’s drug trial fails to hit key target

The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, Nov. 5, 2025. Nichlas Pollier | Bloomberg | Getty Images Shares of Novo Nordisk on Monday fell as much 11% after the Danish drug pharmaceutical company said a highly-anticipated trial for Alzheimer’s disease failed to meet its main goal. The trial tested whether semaglutide — the […]

Read More